Mo1170: IMPACT OF A DNA METHYLATION-BASED ASSAY ON GASTROENTEROLOGISTS’ RECOMMENDATIONS FOR ABLATION AND SURVEILLANCE TIME FOR RISK-STRATIFIED BE PATIENTS: A RANDOMIZED CLINICAL UTILITY STUDY

MLA

David Lu, et al. “Mo1170: IMPACT OF A DNA METHYLATION-BASED ASSAY ON GASTROENTEROLOGISTS’ RECOMMENDATIONS FOR ABLATION AND SURVEILLANCE TIME FOR RISK-STRATIFIED BE PATIENTS: A RANDOMIZED CLINICAL UTILITY STUDY.” Gastroenterology, vol. 162, May 2022, p. S-723. EBSCOhost, https://doi.org/10.1016/s0016-5085(22)61703-7.

APA

David Lu, Shannon Powelson, Ben Merz, Cecelia Nguyen, Dennis Gong, Indu Bastakoti, Sarah Laun, Lisa Kann, Stephen J. Meltzer, & Daniel G. Lunz. (2022). Mo1170: IMPACT OF A DNA METHYLATION-BASED ASSAY ON GASTROENTEROLOGISTS’ RECOMMENDATIONS FOR ABLATION AND SURVEILLANCE TIME FOR RISK-STRATIFIED BE PATIENTS: A RANDOMIZED CLINICAL UTILITY STUDY. Gastroenterology, 162, S-723. https://doi.org/10.1016/s0016-5085(22)61703-7

Chicago

David Lu, Shannon Powelson, Ben Merz, Cecelia Nguyen, Dennis Gong, Indu Bastakoti, Sarah Laun, Lisa Kann, Stephen J. Meltzer, and Daniel G. Lunz. 2022. “Mo1170: IMPACT OF A DNA METHYLATION-BASED ASSAY ON GASTROENTEROLOGISTS’ RECOMMENDATIONS FOR ABLATION AND SURVEILLANCE TIME FOR RISK-STRATIFIED BE PATIENTS: A RANDOMIZED CLINICAL UTILITY STUDY.” Gastroenterology 162 (May): S-723. doi:10.1016/s0016-5085(22)61703-7.